Ignite Creation Date:
2025-12-24 @ 10:49 PM
Ignite Modification Date:
2026-02-26 @ 11:01 AM
Study NCT ID:
NCT00239369
Status:
COMPLETED
Last Update Posted:
2017-12-28
First Post:
2005-10-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Telmisartan80/HCTZ25 Versus Telmisartan80/HCTZ12.5 in Hypertension Not Responding to Telmisartan80/HCTZ12.5
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-10
Start Date Type:
None
Primary Completion Date:
2006-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-08
Completion Date Type:
None
First Submit Date:
2005-10-13
First Submit QC Date:
None
Study First Post Date:
2005-10-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-12-27
Last Update Post Date:
2017-12-28
Last Update Post Date Type:
ACTUAL